Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Figure 1

Immunohistochemistry for VEGFR-3 and CXCR-4 in tumour tissues obtained from patients with esophagogastric adenocarcinoma. A. strong positive staining (>5) for VEGFR-3, B. strong positive staining (>5) for CXCR4 (black arrows).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us